Scott Milsten sold $9.0M of ELF
other at e.l.f. Beauty, Inc.. 64,939 shares at an average of $138.25, traded Jan 2, 2024, filed Jan 4, 2024.
Score components
- +8RoleOther
- +25Trade size$9.0M at market
- +10Share of holdings soldSold 45% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +23.7%, 3m +18.4%, 6m +47.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-24-000010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 2, 2024 | MOption exercise Common Stock, $0.01 par value10b5-1 | +64,939 | $17.00 | $1.1M | 144,043 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -600 | $132.79 | $80k | 143,443 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -1,200 | $134.05 | $161k | 142,243 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -2,814 | $135.36 | $381k | 139,429 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -7,760 | $136.36 | $1.1M | 131,669 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -5,401 | $137.22 | $741k | 126,268 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -24,446 | $138.39 | $3.4M | 101,822 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -10,710 | $139.38 | $1.5M | 91,112 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -11,908 | $139.99 | $1.7M | 79,204 | Jan 4, 2024 |
| Jan 2, 2024 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -100 | $141.47 | $14k | 79,104 | Jan 4, 2024 |
| Jan 2, 2024 | MOption exercise Stock Option (Right to Buy) (Common Stock)derivative10b5-1 | -64,939 | $0.00 | $0 | 32,342 | Jan 4, 2024 |
Related signals
Other insiders at e.l.f. Beauty, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | e.l.f. Beauty, Inc. | Tarang Amin Chief Executive Officer | $4.9M 47,000 shares | -26% | |
| 33Weak | e.l.f. Beauty, Inc. | Mandy J Fields See Remarks | $1.7M 16,065 shares | -15% | |
| 3Weak | e.l.f. Beauty, Inc. | Joshua Allen Franks SVP, Operations | $22k 200 shares | -0% | |
| 29Weak | e.l.f. Beauty, Inc. | Joshua Allen Franks SVP, Operations | $606k 5,512 shares | -4% | |
| 22Weak | e.l.f. Beauty, Inc. | Joshua Allen Franks SVP, Operations | $572k 5,718 shares | -4% | |
| 40Moderate | e.l.f. Beauty, Inc. | Lauren Cooks Levitan director | $96k 1,034 shares | -9% | |
| 28Weak | e.l.f. Beauty, Inc. | Kory Marchisotto See Remarks | $1.1M 12,173 shares | -7% | |
| 33Weak | e.l.f. Beauty, Inc. | Tarang Amin Chief Executive Officer | $3.9M 50,164 shares | -31% | |
| 38Weak | e.l.f. Beauty, Inc. | Jennifer Catherine Hartnett Chief Commercial Officer | $2.0M 25,357 shares | -47% | |
| 68Notable | e.l.f. Beauty, Inc. | Tarang Amin Chief Executive Officer | $822k 15,829 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.